QA07ICD-11 MMS 2026-01
Follow-up examination after treatment for conditions other than malignant neoplasms
Inclusions
- medical surveillance following treatment for conditions other than malignant neoplasms
Excludes
Exclusions from above levels
- http://id.who.int/icd/entity/1144140024 – examinations related to pregnancy and reproduction
- http://id.who.int/icd/entity/1617090159 – Clinical findings in blood, blood-forming organs, or the immune system
Child codes
Sibling codes
QA00– General examination or investigation of persons without complaint or reported diagnosisQA01– Examination or encounter for administrative purposesQA02– Medical observation or evaluation for suspected diseases or conditions, ruled outQA03– Routine general health check-up of defined subpopulationQA04– Examination or observation for reasons other than suspected diseases or conditions or administrative purposesQA05– Person consulting for explanation of investigation findingsQA06– Follow-up examination after treatment for malignant neoplasmsQA08– Special screening examination for infectious diseasesQA09– Special screening examination for neoplasmsQA0A– Special screening examination for other diseases or disordersQA0B– Preprocedural examinationQA0Y– Other examination or investigationQA0Z– Examination or investigation, unspecified
Foundation entity
Follow-up examination after treatment for conditions other than malignant neoplasms – http://id.who.int/icd/entity/81821518
Part of: 24: Factors influencing health status or contact with health services